Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the bodyâs vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
äŒæ¥ã³ãŒãMBOT
äŒç€ŸåMicrobot Medical Inc
äžå Žæ¥Mar 25, 1992
æé«çµå¶è²¬ä»»è
ãCEOãGadot (Harel)
åŸæ¥å¡æ°21
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Mar 25
æ¬ç€Ÿæåšå°175 Derby St Bld 27
éœåžHINGHAM
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·02043
é»è©±çªå·17818753605
ãŠã§ããµã€ãhttp://www.microbotmedical.com/
äŒæ¥ã³ãŒãMBOT
äžå Žæ¥Mar 25, 1992
æé«çµå¶è²¬ä»»è
ãCEOãGadot (Harel)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã